Nrf2's ability to reduce oxidative stress and associated neuroinflammation makes it an attractive therapeutic target for the discovery of novel therapeutic agents for the prevention and treatment of Parkinson's disease and other neurodegenerative diseases [37]. The gene discussed is NFE2L2; the disease is Parkinson disease.